G

PriceGenenta Science

GNTA

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Historical stock price chart and annual return over the past years

-65%

3 years

% Total

GNTA
-23%

3 years

Annual Return

GNTA